Fund shareholders of Krystal Biotech Inc
ISIN US5011471027 · United States · LEI 549300YONUY68210OE41
- Fund shareholders
- 342
- Of which ETFs
- 94 248 other funds
- Value held
- 3.7B $ 403.3M SEK · 52.5K €
- Share of capital
- 48.1 % of 29.6M shares on Jul 28, 2026
342 funds hold this company. This table lists the 341 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| S&P SmallCap 600 Pure Growth Fund Rydex Variable Trust | 228 | 58.9K $ | 0.97 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 207 | 57.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P SmallCap 600 ESG ETF SPDR SERIES TRUST | 200 | 51.7K $ | 0.72 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 197 | 50.9K $ | 0.48 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco S&P SmallCap 600 GARP ETF Invesco Exchange-Traded Fund Trust II | 192 | 52.9K $ | 1.86 % | 0.00 % | as of Feb 28, 2026 ↗ |
| S&P SmallCap 600 Pure Growth Fund Rydex Series Funds | 186 | 48K $ | 0.97 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 169 | 43.7K $ | 0.29 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 151 | 39K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 145 | 38K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 143 | 37.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 142 | 36.7K $ | 0.19 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 140 | 36.7K $ | 0.80 % | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 138 | 35.6K $ | 1.57 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 121 | 31.3K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 119 | 31.2K $ | 0.20 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PGIM Balanced Fund Prudential Investment Portfolios, Inc. | 110 | 28.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 108 | 27.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 106 | 27.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 83 | 21.4K $ | 0.14 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 77 | 20.2K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 75 | 19.4K $ | 0.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Value Tilt ETF SPDR SERIES TRUST | 73 | 18.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 70 | 18.1K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 63 | 16.3K $ | 0.14 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 56 | 14.5K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree U.S. MidCap Quality Growth Fund WisdomTree Trust | 54 | 13.9K $ | 0.69 % | 0.00 % | as of Mar 31, 2026 ↗ |
| RiverNorth Patriot ETF Elevation Series Trust | 53 | 13.7K $ | 0.36 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 45 | 11.8K $ | 0.15 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 37 | 10.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 33 | 8.5K $ | 0.14 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 27 | 7.1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 25 | 6.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 25 | 6.5K $ | 0.21 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 22 | 6.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 15 | 4.1K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Founders 100 ETF Founder Funds Trust | 15 | 3.9K $ | 0.18 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 8 | 2.2K $ | 0.20 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 6 | 1.7K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 6 | 1.5K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 2 | 516.6 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| GESTION BOUTIQUE VII, FI GESTION BOUTIQUE VII / INTERNATIONAL ALPHA ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 52.5K € | 2.13 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 9.30 % | as of Feb 28, 2026 ↗ |
| EVOLUTIONARY TREE INNOVATORS FUND Ultimus Managers Trust | 5.39 % | as of Feb 28, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 5.32 % | as of Mar 31, 2026 ↗ |
| Biondo Focus Fund Northern Lights Fund Trust | 4.71 % | as of Mar 31, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 4.24 % | as of Feb 28, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.51 % | as of Mar 31, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 3.39 % | as of Mar 31, 2026 ↗ |
| Pacer US Small Cap Cash Cows Growth Leaders ETF Pacer Funds Trust | 2.95 % | as of Apr 30, 2026 ↗ |
| Clough Hedged Equity ETF Elevation Series Trust | 2.44 % | as of Apr 30, 2026 ↗ |
| Clough Select Equity ETF Elevation Series Trust | 2.41 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 334 | +19 | 14,083,668 | +2.7 % |
| 2026Q1 | 315 | +7 | 13,715,261 | +0.9 % |
| 2025Q4 | 308 | -1 | 13,596,879 | -0.6 % |
| 2025Q3 | 309 | -35 | 13,681,886 | -2.6 % |
| 2025Q2 | 344 | -10 | 14,051,955 | -5.1 % |
| 2025Q1 | 354 | +8 | 14,809,256 | -2.8 % |
| 2024Q4 | 346 | +18 | 15,240,153 | +2.6 % |
| 2024Q3 | 328 | +58 | 14,861,041 | +33.1 % |
| 2024Q2 | 270 | +9 | 11,168,856 | +10.6 % |
| 2024Q1 | 261 | +17 | 10,099,214 | +7.3 % |
| 2023Q4 | 244 | 9,409,037 |
Institutional managers
359 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 4,373,987 | 1.1B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,940,456 | 1B $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,888,888 | 746.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,314,434 | 339.5M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 1,153,087 | 297.9M $ | as of Mar 31, 2026 |
| Capital World Investors | 824,720 | 213M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 673,505 | 174M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 643,975 | 166.4M $ | as of Mar 31, 2026 |
| Hood River Capital Management LLC | 619,586 | 160.1M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 485,074 | 125.3K $ | as of Mar 31, 2026 |
| Bellevue Group AG | 481,785 | 124.5M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 481,307 | 124.3M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 468,990 | 121.1M $ | as of Mar 31, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 407,178 | 105.2M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 350,521 | 90.5M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 266,659 | 68.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 260,647 | 67.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 252,463 | 65.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 251,373 | 64.9M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 241,986 | 62.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 214,949 | 55.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 209,082 | 54M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 182,425 | 47.1M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 179,265 | 46.3M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 162,070 | 41.9M $ | as of Mar 31, 2026 |
Declared shareholders of Krystal Biotech Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 5.05 % | 1,479,111 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Krystal Biotech Inc". https://titelia.com/en/stocks/krystal-biotech-inc-US5011471027